Company · CTSO
Cytosorbents Corporation
Name as listed on its exchange; filed with the SEC as Cytosorbents Corp.
Nasdaq's symbol directory lists CTSO on Nasdaq as “Cytosorbents Corporation - Common Stock”.
In the 12 months to Nov 8, 2026: insiders bought on 6 occasions ($199K); 1 company report (Form 8-K, since May 26, 2026).
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Phillip P. Chan, Chief Executive Officer bought $128K
- Peter J. Mariani, Chief Financial Officer bought $44K
- Sobel Alan D. bought $15K
- Capponi Vincent, President and COO bought $13K
Every trade (6)
- BUYPhillip P. Chan, Chief Executive Officer bought $23K
- BUYSobel Alan D. bought $15K
- BUYCapponi Vincent, President and COO bought $13K
- BUYPeter J. Mariani, Chief Financial Officer bought $44K
- BUYPhillip P. Chan, Chief Executive Officer bought $4K
- BUYPhillip P. Chan, Chief Executive Officer bought $100K
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Regulation FD disclosure; Other events Sep 23, 2026
Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.